Roivant Sciences Ltd (ROIV)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Revenue | 12.53M | 17.05M | 27.38M | 21.62M | 37.1M | 37.14M | 28.93M | 55.13M |
Operating Income | -280.77M | -378.08M | -234.17M | -276.41M | -276.45M | -287.53M | -266M | -230.57M |
Pre Tax Income | -313.76M | -382.08M | -179.22M | -326.09M | -327.36M | 5.1B | -191.45M | 70.15M |
Net Income | -294.59M | -349.01M | -33.62M | -291.82M | -304.33M | 5.1B | -151.12M | 95.3M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -228.74M | -437.5M | -217.39M | -326.33M | -286.56M | 5.09B | -369.02M | -3.81M |
EBITDA | -273.76M | -372.93M | -228.21M | -270.57M | -270.87M | -282.14M | -260.78M | -225.69M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 67.69M | 23.8M | 55.29M | 61.28M | 124.8M |
Operating Income | -553.81M | -1.07B | -1.35B | -1.18B | -1.11B |
Pre Tax Income | -560.99M | -898.55M | -923.75M | -1.22B | 4.25B |
Net Income | 1.2B | -809.23M | -845.26M | -1.01B | 4.35B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 5.587 | -3.634 | -1.216 | -1.388 | 5.397 |
EBIT | -435.29M | -992.69M | -1.27B | -1.21B | 4.19B |
EBITDA | -553.81M | -1.07B | -1.35B | -1.16B | -1.08B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.